This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Kenta Biotech Ag. Active years: 2009-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2012
Title: **Michael P Horn: Innovator in Monoclonal Antibody Research**
Introduction
Michael P Horn is a notable inventor based in Thun, Switzerland, with a focus on advancements in human monoclonal antibodies. With a total of two patents to his name, he has made significant contributions to the field of biotechnology. His work is primarily centered around developing therapeutic solutions that leverage monoclonal antibodies, showcasing the potential of targeted treatments in medicine.
Latest Patents
Michael P Horn's latest patents include significant innovations related to human monoclonal antibodies specific to various serotypes. One of his patents describes a human monoclonal antibody specific for the serotype IATS O11, involving a hybridoma that produces this antibody, the nucleic acids encoding it, and host cells transfected with these nucleic acids. Additionally, the invention discusses methods for producing the monoclonal antibody and pharmaceutical compositions that include at least one antibody or the nucleic acid encoding it. His other patent focuses on a similar theme, concerning a human monoclonal antibody specific for the serotype IATS 06, further contributing to the advancements in therapeutic applications.
Career Highlights
Michael P Horn is affiliated with Kenta Biotech AG, a company dedicated to developing innovative therapies utilizing monoclonal antibodies. His work exemplifies a commitment to pushing the boundaries of medical science, particularly in creating effective treatment options for various diseases. His expertise and contributions are evident through his patent filings, which reflect his ongoing research and innovations in the field of immunology.
Collaborations
Throughout his career, Michael has worked with esteemed colleagues, including Alois B Lang and Martin A Imboden. These collaborations have fostered a productive research environment, contributing to the development of groundbreaking solutions in the realm of biotechnology and antibody production.
Conclusion
Michael P Horn stands out as an influential inventor within the biotechnology sector, particularly in the advancement of monoclonal antibodies. His contributions not only demonstrate his innovative mindset but also highlight the potential impact of his work on future therapeutic applications. As the medical field continues to evolve, professionals like Michael will play a crucial role in shaping the future of healthcare through their inventions and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile